Cargando…
Central nervous system-related safety and tolerability of add-on ketamine to standard of care treatment in treatment-resistant psychotic depression in patients with major depressive disorder and bipolar disorder
BACKGROUND: Psychotic treatment-resistant depression represents a complex and challenging form of mood disorder in clinical practice. Despite its severity, psychotic depression is frequently underdiagnosed and inadequately treated. Ketamine has demonstrated rapid and potent antidepressant effects in...
Autores principales: | Gałuszko-Wȩgielnik, Maria, Jakuszkowiak-Wojten, Katarzyna, Wiglusz, Mariusz Stanisław, Cubała, Wiesław Jerzy, Pastuszak, Michał |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10366536/ https://www.ncbi.nlm.nih.gov/pubmed/37496742 http://dx.doi.org/10.3389/fnins.2023.1214972 |
Ejemplares similares
-
Ketamine as Add-On Treatment in Psychotic Treatment-Resistant Depression
por: Gałuszko-Węgielnik, Maria, et al.
Publicado: (2023) -
Antianhedonic Effect of Repeated Ketamine Infusions in Patients With Treatment Resistant Depression
por: Wilkowska, Alina, et al.
Publicado: (2021) -
Intravenous Ketamine Infusions in Treatment-Resistant Bipolar Depression: An Open-Label Naturalistic Observational Study
por: Wilkowska, Alina, et al.
Publicado: (2021) -
Magnesium in Ketamine Administration in Treatment-Resistant Depression
por: Górska, Natalia, et al.
Publicado: (2021) -
Central nervous system-related safety and tolerability of add-on
ketamine to antidepressant medication in treatment-resistant depression: focus
on the unique safety profile of bipolar depression
por: Włodarczyk, Adam, et al.
Publicado: (2021)